The higher pre-pregnancy BMI in the Insulin group may have resulted in greater difficulty in glycemic control with diet/physical activity alone, generating the need for complementary treatment with insulin to achieve adequate glycemic control, which is already expected considering that overweight and obesity are important risk factors for GDM. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.